Hemispherian begins clinical trial of GLIX1 for glioblastoma treatment

April 8, 2026 2:30 AM

Hemispherian AS announced the initiation of a Phase 1/2a clinical trial testing GLIX1 in patients with recurrent and progressive glioblastoma ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found